Dolby Laboratories $DLB Shares Purchased by Pacer Advisors Inc.

Pacer Advisors Inc. boosted its stake in shares of Dolby Laboratories (NYSE:DLBFree Report) by 98.2% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 443,897 shares of the electronics maker’s stock after acquiring an additional 219,901 shares during the period. Pacer Advisors Inc. owned about 0.46% of Dolby Laboratories worth $32,125,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in DLB. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in Dolby Laboratories by 7.8% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 15,777 shares of the electronics maker’s stock worth $1,172,000 after buying an additional 1,146 shares during the last quarter. Campbell & CO Investment Adviser LLC lifted its position in shares of Dolby Laboratories by 193.2% in the second quarter. Campbell & CO Investment Adviser LLC now owns 17,275 shares of the electronics maker’s stock valued at $1,283,000 after acquiring an additional 11,384 shares in the last quarter. Boston Trust Walden Corp lifted its position in shares of Dolby Laboratories by 2.1% in the second quarter. Boston Trust Walden Corp now owns 1,098,218 shares of the electronics maker’s stock valued at $81,554,000 after acquiring an additional 22,404 shares in the last quarter. Sequoia Financial Advisors LLC acquired a new stake in shares of Dolby Laboratories in the second quarter worth approximately $550,000. Finally, Clifford Capital Partners LLC increased its position in shares of Dolby Laboratories by 3.1% during the second quarter. Clifford Capital Partners LLC now owns 264,059 shares of the electronics maker’s stock worth $19,609,000 after purchasing an additional 7,871 shares in the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Dolby Laboratories Price Performance

Shares of DLB stock opened at $65.69 on Friday. The company has a market capitalization of $6.27 billion, a PE ratio of 24.98 and a beta of 0.89. The firm’s 50-day moving average is $66.51 and its two-hundred day moving average is $70.85. Dolby Laboratories has a 12 month low of $64.02 and a 12 month high of $89.66.

Dolby Laboratories (NYSE:DLBGet Free Report) last posted its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.29. The business had revenue of $307.02 million during the quarter, compared to analysts’ expectations of $305.76 million. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The business’s revenue for the quarter was up .7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. Sell-side analysts forecast that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were paid a $0.36 dividend. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Tuesday, December 2nd. This represents a $1.44 annualized dividend and a dividend yield of 2.2%. Dolby Laboratories’s dividend payout ratio is currently 54.75%.

Analyst Ratings Changes

DLB has been the topic of a number of research reports. Rosenblatt Securities decreased their price objective on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a report on Wednesday, November 19th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday. Robert W. Baird started coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 price target on the stock. Barrington Research dropped their price objective on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research note on Wednesday, November 19th. Finally, Baird R W raised shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $92.00.

Check Out Our Latest Stock Report on Dolby Laboratories

Insiders Place Their Bets

In related news, EVP Mark Andrew Sherman sold 9,109 shares of the firm’s stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $66.73, for a total transaction of $607,843.57. Following the completion of the sale, the executive vice president directly owned 73,054 shares of the company’s stock, valued at approximately $4,874,893.42. This trade represents a 11.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Kevin J. Yeaman sold 36,699 shares of the business’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $66.91, for a total transaction of $2,455,530.09. Following the completion of the sale, the chief executive officer owned 114,725 shares in the company, valued at approximately $7,676,249.75. This trade represents a 24.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 162,120 shares of company stock valued at $10,906,559. 37.93% of the stock is owned by company insiders.

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Read More

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.